annual EBIT:
-$339.67M-$109.72M(-47.71%)Summary
- As of today (September 16, 2025), SNDX annual earnings before interest & taxes is -$339.67 million, with the most recent change of -$109.72 million (-47.71%) on December 31, 2024.
- During the last 3 years, SNDX annual EBIT has fallen by -$365.89 million (-1395.47%).
- SNDX annual EBIT is now -1395.47% below its all-time high of $26.22 million, reached on December 31, 2021.
Performance
SNDX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
-$63.99M+$12.81M(+16.68%)Summary
- As of today (September 16, 2025), SNDX quarterly earnings before interest & taxes is -$63.99 million, with the most recent change of +$12.81 million (+16.68%) on June 30, 2025.
- Over the past year, SNDX quarterly EBIT has increased by +$4.03 million (+5.92%).
- SNDX quarterly EBIT is now -166.52% below its all-time high of $96.19 million, reached on December 31, 2021.
Performance
SNDX quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$314.25M+$4.03M(+1.27%)Summary
- As of today (September 16, 2025), SNDX TTM earnings before interest & taxes is -$314.25 million, with the most recent change of +$4.03 million (+1.27%) on June 30, 2025.
- Over the past year, SNDX TTM EBIT has dropped by -$50.40 million (-19.10%).
- SNDX TTM EBIT is now -1271.48% below its all-time high of $26.82 million, reached on December 31, 2021.
Performance
SNDX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
SNDX EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -47.7% | +5.9% | -19.1% |
| 3 y3 years | -1395.5% | -73.5% | -10000.0% |
| 5 y5 years | -490.3% | -289.6% | -441.4% |
SNDX EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -1395.5% | at low | -90.1% | +28.4% | <-9999.0% | +1.3% |
| 5 y | 5-year | -1395.5% | at low | -166.5% | +28.4% | -1271.5% | +1.3% |
| alltime | all time | -1395.5% | at low | -166.5% | +28.4% | -1271.5% | +1.3% |
SNDX EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$63.99M(-16.7%) | -$314.25M(-1.3%) |
| Mar 2025 | - | -$76.80M(-14.1%) | -$318.28M(+1.4%) |
| Dec 2024 | -$339.67M(+47.7%) | -$89.36M(+6.3%) | -$313.83M(+5.7%) |
| Sep 2024 | - | -$84.10M(+23.6%) | -$296.88M(+12.5%) |
| Jun 2024 | - | -$68.02M(-6.0%) | -$263.85M(+9.7%) |
| Mar 2024 | - | -$72.34M(-0.1%) | -$240.41M(+14.9%) |
| Dec 2023 | -$229.95M(+51.5%) | -$72.41M(+41.8%) | -$209.15M(+18.9%) |
| Sep 2023 | - | -$51.08M(+14.6%) | -$175.89M(+11.0%) |
| Jun 2023 | - | -$44.58M(+8.5%) | -$158.47M(+5.1%) |
| Mar 2023 | - | -$41.09M(+4.9%) | -$150.77M(+3.1%) |
| Dec 2022 | -$151.76M(-678.8%) | -$39.15M(+16.3%) | -$146.20M(+1246.4%) |
| Sep 2022 | - | -$33.66M(-8.7%) | -$10.86M(-487.0%) |
| Jun 2022 | - | -$36.88M(+1.0%) | $2.81M(-83.9%) |
| Mar 2022 | - | -$36.52M(-138.0%) | $17.41M(-35.1%) |
| Dec 2021 | $26.22M(-136.7%) | $96.19M(-581.2%) | $26.82M(-130.1%) |
| Sep 2021 | - | -$19.99M(-10.3%) | -$89.15M(+0.2%) |
| Jun 2021 | - | -$22.28M(-17.8%) | -$88.97M(+7.0%) |
| Mar 2021 | - | -$27.10M(+37.0%) | -$83.11M(+17.4%) |
| Dec 2020 | -$71.42M(+24.1%) | -$19.79M(-0.1%) | -$70.80M(+8.9%) |
| Sep 2020 | - | -$19.80M(+20.6%) | -$65.01M(+12.0%) |
| Jun 2020 | - | -$16.42M(+11.1%) | -$58.04M(+2.7%) |
| Mar 2020 | - | -$14.79M(+5.6%) | -$56.53M(+0.9%) |
| Dec 2019 | -$57.54M | -$14.00M(+9.1%) | -$56.05M(-5.7%) |
| Sep 2019 | - | -$12.83M(-14.0%) | -$59.47M(-7.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2019 | - | -$14.92M(+4.3%) | -$64.48M(-5.9%) |
| Mar 2019 | - | -$14.30M(-17.9%) | -$68.51M(-7.4%) |
| Dec 2018 | -$75.88M(+22.5%) | -$17.42M(-2.4%) | -$73.96M(-2.7%) |
| Sep 2018 | - | -$17.84M(-5.9%) | -$76.03M(+3.3%) |
| Jun 2018 | - | -$18.95M(-4.1%) | -$73.64M(+7.5%) |
| Mar 2018 | - | -$19.75M(+1.3%) | -$68.53M(+10.6%) |
| Dec 2017 | -$61.95M(+41.6%) | -$19.49M(+26.2%) | -$61.95M(+15.6%) |
| Sep 2017 | - | -$15.45M(+11.6%) | -$53.61M(+0.4%) |
| Jun 2017 | - | -$13.84M(+5.0%) | -$53.40M(+10.8%) |
| Mar 2017 | - | -$13.18M(+18.3%) | -$48.19M(+10.1%) |
| Dec 2016 | -$43.77M(+113.4%) | -$11.14M(-26.9%) | -$43.77M(+34.1%) |
| Sep 2016 | - | -$15.24M(+76.5%) | -$32.63M(+87.6%) |
| Jun 2016 | - | -$8.63M(-1.4%) | -$17.39M(+98.6%) |
| Mar 2016 | - | -$8.75M(+13.1%) | -$8.75M(-58.2%) |
| Dec 2015 | -$20.51M(-3.8%) | - | - |
| Dec 2014 | -$21.33M(+148.9%) | - | - |
| Sep 2014 | - | -$7.74M(+22.3%) | -$20.92M(+35.2%) |
| Jun 2014 | - | -$6.32M(+58.8%) | -$15.47M(+69.1%) |
| Mar 2014 | - | -$3.98M(+38.3%) | -$9.15M(+41.3%) |
| Dec 2013 | -$8.57M(-1.9%) | -$2.88M(+26.1%) | -$6.47M(+80.1%) |
| Sep 2013 | - | -$2.28M(+74.2%) | -$3.60M(+174.2%) |
| Mar 2013 | - | -$1.31M | -$1.31M |
| Dec 2012 | -$8.73M(-9.2%) | - | - |
| Dec 2011 | -$9.62M | - | - |
FAQ
- What is Syndax Pharmaceuticals, Inc. annual earnings before interest & taxes?
- What is the all time high annual EBIT for Syndax Pharmaceuticals, Inc.?
- What is Syndax Pharmaceuticals, Inc. annual EBIT year-on-year change?
- What is Syndax Pharmaceuticals, Inc. quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Syndax Pharmaceuticals, Inc.?
- What is Syndax Pharmaceuticals, Inc. quarterly EBIT year-on-year change?
- What is Syndax Pharmaceuticals, Inc. TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Syndax Pharmaceuticals, Inc.?
- What is Syndax Pharmaceuticals, Inc. TTM EBIT year-on-year change?
What is Syndax Pharmaceuticals, Inc. annual earnings before interest & taxes?
The current annual EBIT of SNDX is -$339.67M
What is the all time high annual EBIT for Syndax Pharmaceuticals, Inc.?
Syndax Pharmaceuticals, Inc. all-time high annual earnings before interest & taxes is $26.22M
What is Syndax Pharmaceuticals, Inc. annual EBIT year-on-year change?
Over the past year, SNDX annual earnings before interest & taxes has changed by -$109.72M (-47.71%)
What is Syndax Pharmaceuticals, Inc. quarterly earnings before interest & taxes?
The current quarterly EBIT of SNDX is -$63.99M
What is the all time high quarterly EBIT for Syndax Pharmaceuticals, Inc.?
Syndax Pharmaceuticals, Inc. all-time high quarterly earnings before interest & taxes is $96.19M
What is Syndax Pharmaceuticals, Inc. quarterly EBIT year-on-year change?
Over the past year, SNDX quarterly earnings before interest & taxes has changed by +$4.03M (+5.92%)
What is Syndax Pharmaceuticals, Inc. TTM earnings before interest & taxes?
The current TTM EBIT of SNDX is -$314.25M
What is the all time high TTM EBIT for Syndax Pharmaceuticals, Inc.?
Syndax Pharmaceuticals, Inc. all-time high TTM earnings before interest & taxes is $26.82M
What is Syndax Pharmaceuticals, Inc. TTM EBIT year-on-year change?
Over the past year, SNDX TTM earnings before interest & taxes has changed by -$50.40M (-19.10%)